Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Interchangeable Reactor Tray

By Drug Discovery Trends Editor | March 10, 2009

Uniqsis' Cold Tray Reactor ModuleA new interchangeable reactor tray is now available for the Uniqsis FlowSyn Continuous Flow Reactor that extends the system’s working temperature range down to -40°C. The ‘Cold Tray’ Reactor Module was developed in response to user requests for sub-ambient capability and can be fitted retrospectively to existing FlowSyn systems in a few minutes. Used with a suitable heater/chiller unit – both M16 and barbed connections are available for freedom of choice –  and an appropriate thermal fluid the system has a validated temperature range from -40°C to +150°C, and will maintain stable low temperature conditions for extended periods, according to Uniqsis. Control is via the standard FlowSyn user interface for added convenience – no additional PC is required so the complete system has a very small footprint.

The Cold Tray can be used with the novel Uniqsis coiled tubing reactors, with column reactors, or a combination of both. Two tubing reactors can be simultaneously fitted to the cooled coil module and interconnected via a T-piece, allowing the low temperature introduction of reagents at an intermediate stage of the reaction. Exothermic mixing can be controlled by fitting a glass mixer block cooled to the same temperature as the reactor so that precise temperature control is achieved at the point of mixing. The Cold Tray is also fully compatible with the recently introduced FlowSyn Multiple Experiment Package, capable of running up to 10 sequential experiments with different reaction times, temperatures, and reagent stoichiometries, and ideal for reaction profiling and optimisation studies.

www.uniqsis.com


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE